[HTML][HTML] An infectious SARS-CoV-2 B. 1.1. 529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies

LA VanBlargan, JM Errico, PJ Halfmann, SJ Zost… - Nature medicine, 2022 - nature.com
The emergence of the highly transmissible B. 1.1. 529 Omicron variant of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is concerning for antibody …

[PDF][PDF] An infectious SARS-CoV-2 B. 1.1. 529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies

L VanBlargan, J Errico, P Halfmann, S Zost, J Crowe… - scienceopen.com
The emergence of the highly-transmissible B. 1.1. 529 Omicron variant of Severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is concerning for antibody …

[HTML][HTML] An infectious SARS-CoV-2 B. 1.1. 529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies

L VanBlargan, J Errico, P Halfmann, S Zost, J Crowe… - 2021 - europepmc.org
The emergence of the highly-transmissible B. 1.1. 529 Omicron variant of Severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is concerning for antibody …

An infectious SARS-CoV-2 B. 1.1. 529 Omicron virus escapes neutralization by several therapeutic monoclonal antibodies

LA VanBlargan, JM Errico, P Halfmann, SJ Zost… - 2021 - pesquisa.bvsalud.org
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by several
therapeutic monoclonal antibodies | PREPRINT-BIORXIV loading 1 2 3 +A A -A 3.An infectious …

An infectious SARS-CoV-2 B. 1.1. 529 Omicron virus escapes neutralization by several therapeutic monoclonal antibodies

LA VanBlargan, JM Errico, PJ Halfmann, SJ Zost… - bioRxiv, 2021 - biorxiv.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the global
COVID-19 pandemic resulting in millions of deaths worldwide. Despite the development and …

An infectious SARS-CoV-2 B. 1.1. 529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies

L VanBlargan, J Errico, P Halfmann, S Zost, J Crowe… - Nat Med, 2021 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> The emergence of the highly-transmissible B.
1.1. 529 Omicron variant of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

[PDF][PDF] An infectious SARS-CoV-2 B. 1.1. 529 Omicron virus escapes neutralization by several therapeutic monoclonal antibodies 2

LA VanBlargan, JM Errico, PJ Halfmann, SJ Zost… - scholar.archive.org
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by several
therapeutic monoclonal antibodies Page 1 1 An infectious SARS-CoV-2 B.1.1.529 Omicron …

[HTML][HTML] An infectious SARS-CoV-2 B. 1.1. 529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies

LA VanBlargan, JM Errico, PJ Halfmann, SJ Zost… - Nature …, 2022 - ncbi.nlm.nih.gov
The emergence of the highly transmissible B. 1.1. 529 Omicron variant of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is concerning for antibody …

[PDF][PDF] An infectious SARS-CoV-2 B. 1.1. 529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies

L VanBlargan, J Errico, P Halfmann, S Zost, J Crowe… - pdfs.semanticscholar.org
The emergence of the highly-transmissible B. 1.1. 529 Omicron variant of Severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is concerning for antibody …

An infectious SARS-CoV-2 B. 1.1. 529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies

LA VanBlargan, JM Errico, PJ Halfmann… - Nature …, 2022 - pubmed.ncbi.nlm.nih.gov
The emergence of the highly transmissible B. 1.1. 529 Omicron variant of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is concerning for antibody …